Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 4/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | CPA1 | P15085 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | MME | P08473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodomethane SCHEMBL871394 | 0.96 | KISS1R (0.43) | KISS1RSLC1A3SLC1A2CPA1NPC1 | |
| Oxalic Acid SCHEMBL19024409 | 0.94 | KISS1R (0.42) | KISS1RSLC1A3SLC1A2CPA1NPC1 | |
| Heptane SCHEMBL19024431 | 0.89 | KISS1R (0.42) | KISS1RMAPK1MMP8 | |
| Citric Acid SCHEMBL19024416 | 0.82 | ALDH1A1 (0.46) | KISS1RSLC1A3SLC1A2MAPTMAPK1 | |
| SCHEMBL5672721 | 0.80 | KISS1R (0.61) | KISS1RSLC1A3SLC1A2CPA1MME | |
| SCHEMBL27527680 | 0.78 | KISS1R (0.59) | KISS1RSLC1A3SLC1A2CPA1MME | |
| Ammonia Solution, Strong SCHEMBL27748255 | 0.78 | KISS1R (0.59) | KISS1RSLC1A3SLC1A2CPA1MME | |
| SCHEMBL16512045 | 0.77 | ANPEP (0.30) | — | |
| SCHEMBL18934271 | 0.76 | TSHR (0.46) | SLC1A3SLC1A2NPC1MAPTMAPK1 | |
| SCHEMBL16599080 | 0.75 | CYP3A4 (0.39) | MAPTHTTRAB9AATMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110143889-B | Synthetic method of 3- [ (dimethylamino) methyl ] -5-methyl-2-hexanone | 江苏暨明医药科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| EP-3394057-B1 | SYNTHETIC METHOD FOR PREPARATION OF (S)-(2R,3R,11BR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11B-HEXAHYDRO-1H-PYRIDO[2,1,-A]LSOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) | NEUROCRINE BIOSCIENCES INC (US) | 2022-03-30 | — | — | EP | claimed |
| US-10160757-B2 | Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) | Neuroscrine Biosciences, Inc. (US) | 2018-12-25 | — | — | US | claimed |
| EP-3394057-A1 | SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11BR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11B-HEXAHYDRO-1H-PYRIDO[2,1,-A]lSOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) | Neurocrine Biosciences Inc. (US) | 2018-10-31 | — | — | EP | claimed |
| WO-2017112857-A1 | SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11BR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11B-HEXAHYDRO-1H-PYRIDO[2,1,-A]lSOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) | NEUROCRINE BIOSCIENCES, INC. (US) | 2017-06-29 | — | — | WO | claimed |
| US-20170183346-A1 | SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11bR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11b-HEXAHYDRO-1H-PYRIDO[2,1-a]ISOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) | AGNO PHARMA USA | 2017-06-29 | — | — | US | claimed |
| US-20260144785-A1 | ANALOGS OF DEUTETRABENAZINE, THEIR PREPARATION AND USE | AUSPEX PHARMACEUTICALS LLC (US) | 2026-05-28 | — | — | US | disclosed |
| US-12502385-B2 | Analogs of deutetrabenazine, their preparation and use | AUSPEX PHARMACEUTICALS LLC (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250326747-A1 | Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 | AUSPEX PHARMACEUTICALS LLC | 2025-10-23 | — | — | US | disclosed |
| US-20240307371-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS LLC | 2024-09-19 | — | — | US | disclosed |
| US-12077487-B2 | Methods of manufacturing benzoquinoline compounds | AUSPEX PHARMACEUTICALS, INC. (US) | 2024-09-03 | — | — | US | disclosed |
| US-20240239791-A1 | PROCESSES FOR THE SYNTHESIS OF VALBENAZINE | NEUROCRINE BIOSCIENCES, INC. | 2024-07-18 | — | — | US | disclosed |
| US-20240239791-A1 | PROCESSES FOR THE SYNTHESIS OF VALBENAZINE | NEUROCRINE BIOSCIENCES, INC. | 2024-07-18 | — | — | US | disclosed |
| WO-2010026436-A2 | PHARMACEUTICAL COMPOUNDS | BIOVAIL LABORATORIES INTERNATIONAL (BARBADOS) SRL (BB) | 2010-03-11 | — | — | WO | disclosed |
| EP-2081929-A1 | SUBSTITUTED 3-ISOBUTYL-9, 10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDOÝ2,1-A¨ISOQUINOLIN-2-OL COMPOUNDS AND METHODS RELATING THERETO | NEUROCRINE BIOSCIENCES, INC. (US) | 2009-07-29 | — | — | EP | disclosed |
| US-20080167337-A1 | SUBSTITUTED 3-ISOBUTYL-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLIN-2-OL COMPOUNDS AND METHODS RELATING THERETO | NEUROCRINE BIOSCIENCES, INC. | 2008-07-10 | — | — | US | disclosed |
| WO-2008058261-A1 | SUBSTITUTED 3-ISOBUTYL-9, 10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A] ISOQUINOLIN-2-OL COMPOUNDS AND METHODS RELATING THERETO | NEUROCRINE BIOSCIENCES, INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| US-20080050312-A1 | Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2008-02-28 | — | — | US | disclosed |
| US-20080050312-A1 | Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2008-02-28 | — | — | US | disclosed |
| WO-2007130365-A2 | RADIOLABELED DIHYDROTETRABENAZINE DERIVATIVES AND THEIR USE AS IMAGING AGENTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170183346-A1 | SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11bR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11b-HEXAHYDRO-1H-PYRIDO[2,1-a]ISOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) | CYP2S1, CYP26B1, CYP4B1 | KISS1R 3807/4885SLC1A3 1877/4885SLC1A2 3002/4885 |
| US-20240307371-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | SLC18A2, SLC6A2, SLC18A1 | KISS1R 2011/4885SLC1A3 19/4885SLC1A2 7/4885 |
| US-20240239791-A1 | PROCESSES FOR THE SYNTHESIS OF VALBENAZINE | SLC18A2, SLC18A3, SLC6A3 | KISS1R 2584/4885SLC1A3 14/4885SLC1A2 6/4885 |
| US-12502385-B2 | Analogs of deutetrabenazine, their preparation and use | UGT1A8, UGT1A4, CYP2C8 | KISS1R 4273/4885SLC1A3 4270/4885SLC1A2 3754/4885 |
| US-10160757-B2 | Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) | CYP2S1, CYP26B1, CYP4B1 | KISS1R 3807/4885SLC1A3 1877/4885SLC1A2 3002/4885 |
| US-20260144785-A1 | ANALOGS OF DEUTETRABENAZINE, THEIR PREPARATION AND USE | SLC6A2, SLC18A2, SLC6A3 | KISS1R 1657/4885SLC1A3 91/4885SLC1A2 12/4885 |
| US-20080167337-A1 | SUBSTITUTED 3-ISOBUTYL-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLIN-2-OL COMPOUNDS AND METHODS RELATING THERETO | SLC18A2, SLC6A2, SLC18A3 | KISS1R 2503/4885SLC1A3 74/4885SLC1A2 28/4885 |
| US-20250326747-A1 | Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 | SLC18A2, SLC6A2, SLC18A1 | KISS1R 2011/4885SLC1A3 19/4885SLC1A2 7/4885 |
| US-12077487-B2 | Methods of manufacturing benzoquinoline compounds | SLC18A2, SLC18A1, SLC6A2 | KISS1R 1116/4885SLC1A3 50/4885SLC1A2 8/4885 |
| US-20080050312-A1 | Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents | SLC18A2, SLC18A3, SLC6A2 | KISS1R 1303/4885SLC1A3 19/4885SLC1A2 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.